Cargando…
SARS-CoV-2 triggering autoimmune diseases
Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, byst...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979824/ https://www.ncbi.nlm.nih.gov/pubmed/35461172 http://dx.doi.org/10.1016/j.cyto.2022.155873 |
_version_ | 1784681261918322688 |
---|---|
author | Mobasheri, Leila Nasirpour, Mohammad Hossein Masoumi, Elham Azarnaminy, Afsaneh Foolady Jafari, Mozhdeh Esmaeili, Seyed-Alireza |
author_facet | Mobasheri, Leila Nasirpour, Mohammad Hossein Masoumi, Elham Azarnaminy, Afsaneh Foolady Jafari, Mozhdeh Esmaeili, Seyed-Alireza |
author_sort | Mobasheri, Leila |
collection | PubMed |
description | Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as “cytokine storm,” and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4(+) and CD8(+) T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease. |
format | Online Article Text |
id | pubmed-8979824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89798242022-04-05 SARS-CoV-2 triggering autoimmune diseases Mobasheri, Leila Nasirpour, Mohammad Hossein Masoumi, Elham Azarnaminy, Afsaneh Foolady Jafari, Mozhdeh Esmaeili, Seyed-Alireza Cytokine Article Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as “cytokine storm,” and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4(+) and CD8(+) T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease. Elsevier Ltd. 2022-06 2022-04-05 /pmc/articles/PMC8979824/ /pubmed/35461172 http://dx.doi.org/10.1016/j.cyto.2022.155873 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mobasheri, Leila Nasirpour, Mohammad Hossein Masoumi, Elham Azarnaminy, Afsaneh Foolady Jafari, Mozhdeh Esmaeili, Seyed-Alireza SARS-CoV-2 triggering autoimmune diseases |
title | SARS-CoV-2 triggering autoimmune diseases |
title_full | SARS-CoV-2 triggering autoimmune diseases |
title_fullStr | SARS-CoV-2 triggering autoimmune diseases |
title_full_unstemmed | SARS-CoV-2 triggering autoimmune diseases |
title_short | SARS-CoV-2 triggering autoimmune diseases |
title_sort | sars-cov-2 triggering autoimmune diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979824/ https://www.ncbi.nlm.nih.gov/pubmed/35461172 http://dx.doi.org/10.1016/j.cyto.2022.155873 |
work_keys_str_mv | AT mobasherileila sarscov2triggeringautoimmunediseases AT nasirpourmohammadhossein sarscov2triggeringautoimmunediseases AT masoumielham sarscov2triggeringautoimmunediseases AT azarnaminyafsanehfoolady sarscov2triggeringautoimmunediseases AT jafarimozhdeh sarscov2triggeringautoimmunediseases AT esmaeiliseyedalireza sarscov2triggeringautoimmunediseases |